|
WO1997046256A1
(en)
*
|
1996-05-23 |
1997-12-11 |
The Scripps Research Institute |
Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
ATE437366T1
(de)
|
1998-05-11 |
2009-08-15 |
Miltenyi Biotec Gmbh |
Verfahren zur direkten auswahl von antigen- spezifischen t-zellen
|
|
US6230662B1
(en)
|
1998-06-22 |
2001-05-15 |
Theresa Miale |
Animal lift and transport apparatus and method for using the same
|
|
AU5474399A
(en)
*
|
1998-08-10 |
2000-03-06 |
Chiron Corporation |
Engineered antigen-presenting cells expressing an array of antigens and uses thereof
|
|
CA2345277C
(en)
|
1998-10-20 |
2011-05-24 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
US6225443B1
(en)
*
|
1999-05-19 |
2001-05-01 |
Wisconsin Alumni Research Foundation |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
|
|
US7521202B2
(en)
|
1999-12-17 |
2009-04-21 |
The Board Of Regents Of The University Of Oklahoma |
Method and apparatus for the production of soluble MHC antigens and uses thereof
|
|
DE10009341A1
(de)
*
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
AU2000243137A1
(en)
*
|
2000-04-20 |
2001-11-07 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
DE60138922D1
(de)
|
2000-10-10 |
2009-07-16 |
Univ Oklahoma |
Vergleichende ligandenabbildung aus mhc-positiven zellen
|
|
US20070026433A1
(en)
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002056908A2
(en)
*
|
2001-01-16 |
2002-07-25 |
Hildebrand William H |
Artificial antigen-presenting cells
|
|
AU2002255532A1
(en)
*
|
2001-02-13 |
2002-10-15 |
Joseph D. Mosca |
Biological carriers for induction of immune responses
|
|
US20040071671A1
(en)
*
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
JP2006510567A
(ja)
*
|
2001-02-20 |
2006-03-30 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
腫瘍の治療のための細胞治療方法
|
|
FR2824567B1
(fr)
*
|
2001-05-11 |
2003-08-08 |
Inst Nat Sante Rech Med |
Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US7670781B2
(en)
*
|
2002-01-03 |
2010-03-02 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal
|
|
US7638326B2
(en)
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
US20040072262A1
(en)
*
|
2002-10-11 |
2004-04-15 |
Montero-Julian Felix A. |
Methods and systems for detecting MHC class I binding peptides
|
|
EP1808200A3
(en)
*
|
2002-10-11 |
2007-09-19 |
Sentoclone AB |
Cancer immuno-therapy
|
|
US7435592B2
(en)
|
2003-05-13 |
2008-10-14 |
Immunovative Therapies, Ltd. |
Compositions for allogeneic cell therapy
|
|
JP2007511760A
(ja)
*
|
2003-11-03 |
2007-05-10 |
ベックマン コールター インコーポレーティッド |
Ｍｈｃ結合ペプチドを検出するための溶液ベースの方法
|
|
LT2573166T
(lt)
|
2004-02-26 |
2016-09-26 |
Immunovative Therapies, Ltd. |
T ląstelių paruošimo būdas ląstelių terapijai
|
|
US7592431B2
(en)
|
2004-02-26 |
2009-09-22 |
Immunovative Therapies, Ltd. |
Biodegradable T-cell Activation device
|
|
JP2007536522A
(ja)
*
|
2004-05-07 |
2007-12-13 |
ベックマン コールター インコーポレーティッド |
Ｃｔｌの媒介による抗原提示細胞の溶解を検出するためのｍｈｃ架橋系
|
|
WO2005118788A2
(en)
|
2004-05-27 |
2005-12-15 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
EP2226332A1
(en)
*
|
2004-06-17 |
2010-09-08 |
Beckman Coulter, Inc. |
Mycobacterium tuberculosis epitopes and methods of use thereof
|
|
EP1712615A1
(en)
*
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
BRPI0611766A2
(pt)
|
2005-06-08 |
2011-12-20 |
Dana Farber Cancer Institute |
métodos e composições para o tratamento de infecções persistentes e cáncer por inibição da rota de morte celular programada
|
|
WO2006138449A2
(en)
*
|
2005-06-16 |
2006-12-28 |
The Wistar Institute |
Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen
|
|
JP5205275B2
(ja)
|
2005-12-21 |
2013-06-05 |
セントクローネ インターナショナル エービー |
散在性ガンの治療法
|
|
WO2007071388A1
(en)
|
2005-12-21 |
2007-06-28 |
Sentoclone Ab |
Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer
|
|
AU2006328945B2
(en)
|
2005-12-21 |
2011-06-30 |
Sentoclone International Ab |
Method for treating malignant melanoma
|
|
US8101173B2
(en)
|
2005-12-21 |
2012-01-24 |
Sentoclone International Ab |
Method for treating urinary bladder cancer
|
|
JP2009531303A
(ja)
*
|
2006-03-01 |
2009-09-03 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
リンパ球枯渇剤をｃｔｌおよびサイトカインと組合せる癌処置
|
|
US8124408B2
(en)
*
|
2006-10-04 |
2012-02-28 |
Janssen Pharmaceutica N.V. |
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
|
|
NZ600281A
(en)
*
|
2006-12-27 |
2013-03-28 |
Harvard College |
Compositions and methods for the treatment of infections and tumors
|
|
US20110092961A1
(en)
*
|
2008-08-13 |
2011-04-21 |
Searete Llc |
Artificial cells
|
|
EP2370593B1
(en)
*
|
2008-11-28 |
2016-03-30 |
Emory University |
Methods for determining the efficacy of pd-1 antagonists
|
|
US8075895B2
(en)
*
|
2009-09-22 |
2011-12-13 |
Janssen Pharmaceutica N.V. |
Identification of antigenic peptides from multiple myeloma cells
|
|
EP2404618A1
(en)
|
2010-07-07 |
2012-01-11 |
Stichting Katholieke Universiteit meer in het bijzonder Radboud Universiteit Nijmegen |
Immunomodulatory protein constructs with a helical polymeric backbone.
|
|
CA2799516C
(en)
*
|
2010-08-06 |
2016-01-05 |
Canine-Lab.Inc. |
Immunological function enhancing agent
|
|
JP6393186B2
(ja)
|
2011-05-03 |
2018-09-19 |
イミュノバティブ セラピーズ，リミテッド |
免疫療法を用いたｉｌ−１２の誘導
|
|
EP2704741B1
(en)
|
2011-05-03 |
2017-08-23 |
Immunovative Therapies, Ltd. |
Methods for handling biological drugs containing living cells
|
|
EP3567102A1
(en)
|
2012-04-24 |
2019-11-13 |
Dan S. Kaufman |
Method for developing natural killer cells from stem cells
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
SG11201604868YA
(en)
|
2013-12-16 |
2016-07-28 |
Us Health |
Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
|
|
DK3105335T3
(da)
|
2014-02-14 |
2020-01-13 |
Univ Texas |
Kimære antigenreceptorer og fremgangsmåder til fremstilling heraf
|
|
US10857219B2
(en)
|
2014-03-28 |
2020-12-08 |
The Board Of Regents Of The University Of Oklahoma |
Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof
|
|
EP3134437A1
(en)
|
2014-04-23 |
2017-03-01 |
Board of Regents, The University of Texas System |
Chimeric antigen receptors (car) for use in therapy and methods for making the same
|
|
ES2730325T3
(es)
|
2014-04-24 |
2019-11-11 |
Univ Texas |
Aplicación de citoblastos pluripotentes inducidos para generar productos de terapia celular adoptiva
|
|
WO2016073629A1
(en)
|
2014-11-05 |
2016-05-12 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
CN107207615A
(zh)
|
2014-11-05 |
2017-09-26 |
得克萨斯州大学系统董事会 |
基因修饰的免疫效应细胞和用于扩增免疫效应细胞的工程化细胞
|
|
FR3031519B1
(fr)
|
2015-01-14 |
2016-12-30 |
Arkema France |
Composition a base de terpolymere electroactif
|
|
ES2790725T3
(es)
*
|
2015-03-16 |
2020-10-29 |
Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft |
Procedimiento de detección de nuevos epítopos de células T inmunogénicas y aislamiento de nuevos receptores de células T específicas de antígeno mediante una biblioteca de células de MHC
|
|
WO2017075147A1
(en)
|
2015-10-27 |
2017-05-04 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
CA3025667A1
(en)
|
2016-06-08 |
2017-12-14 |
Intrexon Corporation |
Cd33 specific chimeric antigen receptors
|
|
BR112019001327A2
(pt)
|
2016-07-29 |
2019-04-30 |
Juno Therapeutics Inc |
anticorpos anti-idiotípicos e métodos relacionados
|
|
CA3043356A1
(en)
|
2016-11-09 |
2018-05-17 |
Musc Foundation For Research Development |
Cd38-nad+ regulated metabolic axis in anti-tumor immunotherapy
|
|
CA3049652A1
(en)
|
2017-01-10 |
2018-07-19 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
US11285196B2
(en)
|
2017-03-13 |
2022-03-29 |
Eslam Abbas Baseuny |
Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
|
|
CN110891967B
(zh)
|
2017-04-18 |
2025-03-14 |
富士胶片细胞动力公司 |
抗原特异性免疫效应细胞
|
|
WO2018226897A1
(en)
|
2017-06-07 |
2018-12-13 |
Intrexon Corporation |
Expression of novel cell tags
|
|
CN119930795A
(zh)
|
2017-10-12 |
2025-05-06 |
得克萨斯大学体系董事会 |
用于免疫疗法的t细胞受体
|
|
CN111918661A
(zh)
|
2018-02-21 |
2020-11-10 |
得克萨斯大学体系董事会 |
用于活化和扩增自然杀伤细胞的方法及其用途
|
|
AU2019386140A1
(en)
|
2018-11-28 |
2021-06-24 |
Board Of Regents, The University Of Texas System |
Multiplex genome editing of immune cells to enhance functionality and resistance to suppressive environment
|
|
MX2021006393A
(es)
|
2018-11-29 |
2021-10-13 |
Univ Texas |
Metodos para expansion ex vivo de celulas exterminadoras naturales y uso de las mismas.
|
|
CN120605327A
(zh)
|
2019-11-06 |
2025-09-09 |
贝勒医学院 |
用于产生细胞毒性效应子记忆t细胞以用于癌症的t细胞治疗的方法
|
|
US20230079539A1
(en)
|
2020-02-10 |
2023-03-16 |
Board Of Regents, The University Of Texas System |
Methods for rapid cloning and expression of hla class i cells
|
|
EP4157864A1
(en)
|
2020-05-27 |
2023-04-05 |
Antion Biosciences SA |
Adapter molecules to re-direct car t cells to an antigen of interest
|
|
US12275766B2
(en)
|
2020-12-23 |
2025-04-15 |
Janssen Biotech, Inc. |
Neoantigen peptide mimics
|
|
EP4514382A1
(en)
|
2022-04-28 |
2025-03-05 |
Musc Foundation for Research Development |
Chimeric antigen receptor modified regulatory t cells for treating cancer
|